Kidney diseases in Africa: Aetiological considerations, peculiarities and burden

Abstract

Aim: To review available literature on the burden of kidney diseases in Africa from the perspective of acute kidney injury and chronic kidney disease. It also aims to provide information on the status of renal replacement therapy activities, and the emerging roles ofthe double burden of communicable and non communicable diseases interfacing with the kidney in a continent with distinct environmental, socio-cultural, infrastructural and economical peculiarities.

Methods: A literature search was conducted on the aetiopathogenesis, management options of peculiar diseases causing both acute kidney injury and chronic kidney diseases and renal replacement therapies in Africa. The literature review used the electronic database; Medline, Pubmed and the African Journal on line (AJOL). Information related to the topic over a 30-year period (1979-2009) was retrieved and reviewed. Search terms used were ; acute renal failure in Africa, acute kidney injury in Africa, chronic renal failure/chronic kidney disease in Africa, heamodialysis, peritoneal dialysis and transplantation in Africa.

Result: Nephrotoxins and infections are prevalent causes of acute kidney injury (AKI) in the continent. Chronic glomerulonephritis, hypertension and lately diabetes mellitus are still major peculiar aetiological factors of chronic kidney disease (CKD). A variety of renal syndromes which can be acute or chronic is associated with the Human immunodiefficency virus infection and its magnitude and consequences portend a grim reality in a continent that is least prepared to respond appropriately. Renal replacement therapy therapy is limited to less than five percent of those that need it especially in the sub-Saharan Africa.

Conclusion: There is a huge burden of AKI and CKD in Africa from the perspective of their peculiar aetiological considerations. The status of renal replacement therapy activities is poor except in North and South Africa. The major challenges of kidney diseases in Africa include the high prevalence, delayed presentation, cost of treatment, general lack of preventive measures, lack of epidemiological studies and general lack of functional renal registries. There is thus a need for a strong advocacy for support for renal care in Africa.

Keywords: Kidney, socio-cultural, aetiopatho- genesis, heamodialysis; renal failure

Résumé
But: Passer en revue Les Documents disponibles sur les charges des maladies rénales en Afrique dans la perspective de l’insuffisance rénale aiguë et la maladie rénale chronique. Il vise également à fournir des informations sur le statut de la fonction rénale des activités de remplacement thérapeutique, et les nouveaux rôles de la double charge des maladies transmissibles et non transmissibles en interface avec le rein dans un continent des spécifiés environnementales, socioculturelles, infrastructurelles et économiques.

Méthodes: Une recherche bibliographique a été menée sur l’ étiopathogénie, les options de gestion des maladies particulières provoquant à la fois l’insuffisance rénale aiguë et de maladies rénales chroniques et des thérapies de remplacement rénal en Afrique. La revue des documents a utilisé des données de base électronique; Medline, Pubmed et le Journal Africain en ligne (JAL). Les informations relatives à ce sujet au cours d’une période de 30 ans (1979-2009) ont été récupérées et examinées. Les termes de recherche utilisés étaient : l’insuffisance rénale aiguë en Afrique, l’insuffisance rénale chronique en Afrique, l’hémodialyse, la dialyse péritonéale et la transplantation en Afrique.

Résultat: Les néphrotomies et les infections sont les causes courantes de l’insuffisance rénale aiguë sur le continent. La glomérulonéphrite chronique, l’hypertension et le diabète tardif sont encore les principaux facteurs étiologiques particuliers de CKD. Une variété de syndromes rénaux qui peut être aiguë ou chronique est associée à l’infection par le virus immunodéficience de l’homme, son ampleur et les conséquences laissent présager une triste réalité sur un continent qui est le moins disposé à répondre de manière appropriée. La thérapie par remplacement rénal est limitée à moins de cinq pour cent de ceux qui en ont besoin en particulier en l’Afrique sub-saharienne.

Conclusion: Il ya une charge énorme de la AKI et CKD en Afrique du point de vue de leurs propres considérations étiologiques. Le statut de la fonction rénale des activités de remplacement thérapeutique est faible, sauf en Afrique du nord et l’Afrique du Sud. Les défis majeurs des maladies rénales en Afrique comprennent la forte prévalence, la présentation tardive, le coût du traitement, le manque général de mesures préventives, le manque d’études épidémiologiques et le manque général de registres fonctionnels rénaux. Il ya donc un besoin urgent d’un plaidoyer fort pour soutenir les soins rénaux en Afrique.

Correspondence: Prof. A. Akinsola, Department of Medicine, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria. E-mail: wakinsol46@yahoo.co.uk

pdf (inglese)

Riferimenti bibliografici

Africa.Available at http://www. en.wikipedia.

org/wiki.Africa. Accessed January 2, 2010.

UNDP. Statistics. Human Development report. Available at www.hdr.undp.org/en/statistics. Accessed on January 27, 2010.

World Bank. Regional fact sheet from the World Development Indicators 2007. Sub-Sharan Africa. 2007. Available at http://www.rrojasdatabank.info/wdi 2007/regionsheets.pdf (Accessed December 6, 2008).

Frenk J, Bobadilla JL, Sepulveda J and Cervantes LM: Health transition in middle-income countries: new challenges for health care. Health Policy Plan 1989; 4: 29 – 39.

Lameire N, Van Biesen W, Vanholder R; Acute Renal Failure; Lancet. 2005: 365; 417 – 430.

Bellomo R, Ronco C, kellum et al. Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care.2004; 8: R204-R212

Mehta RL, Kellum JA, Shah SV et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007; 11: R31

Nissenson AR. Acute Renal Failure; Definition and Pathogenesis. Kidney Int. 1998; 53, Suppl. 66: S-7-S-10

Seedat YK and Nathoo BC, Acute Renal Failure in Blacks and Indians in South Africa. Comparison after 10 years. Nephron 1993; 64: 198 – 201

Anochie IG and Eke FU. Acute Renal Failure in Nigerian Children; Port Harcourt Experience. Pediatr Nephrol. 2005;20 : 1610 – 1614

Bamgboye EL, Mabayoje MO, Odutola TA et al. Acute renal Failure at the Lagos University Teaching Hospital; a 10 year review. Ren. Fail 1993; 15: 77 – 80

Seedat YK, North-Coombes D and Sewardseen M. A study of Acute Renal Failure in Fifty South African Black Patients. Kidney Int;1976; 9(4): 379

Sulieman SM, Acute Renal Failure in Sudan. Saudi J. Kidney Dis Transpl. 1998; 9: 316 – 318

Assounga AG, Yala F, Mongo Y. et al. HIV and Nephropathy in the Congo; a comparison of HIV-positive Vs HIV-negative. Saudi J. Kidney Dis. Transpl. 1996; 7: S30 – 32

Ekwere TG. Pattern of Acute Renal Failure in Ile-Ife, Nigeria. Postgraduate Medical College of Nigeria. (Nephrology Sub Specialty) Dissertation. November 1996.

Bahloul M, Ben Hamida C, Damak H et al. Incidence and Prognosis of Acute Renal Failure in the Intensive Care Unit. Retrospective Study of 216 Cases. Tunis Med. 2003;April 81(4): 250-257

Kaballo BG, Khogali MS and Khalifa EH. Patterns of “Severe Acute Renal Failure” in a referral Centre in Sudan: Excluding intensive Care and major surgery patients. Saudi J. Kidney Dis Transpl. 2007. Jun; 10 (2): 220 – 225

Khosla SN and Lochan R. Renal dysfunction in Enteric Fever. J. Assoc. Physicians, India 1991 May; 38(5): 382 – 384

Assounga AG, Assambo-Kieli C, Mafoua A et al. Etiology and Outcome of Acute Renal Failure in Children in Congo-Brazzaville. Saudi J. Kidney Dis Transpl. 2000; 11:40 – 43

Sakjuja V and Sud K. Acute Renal Failure in the Tropics. Saudi J. Kidney Dis. Transpl. 1998; 9: 247 – 260

Martinelli R, Matos CM and Roche H. Tetanus as a cause of acute renal failure: possible role of rhabdomyolysis. Rev. Soc Bras Med. Trop 1993. Jan – March; 26 (1) 1-4

Daher EF. Prospective study of tetanus induced acute renal dysfunction: Role of Adrenergic Overactivity. Am J. Trop Med. Hyg. 1997. Nov; 57 (5):610 – 614

Wilkins RG and Faragher EB: Acute Renal Failure in an Intensive Care Unit. Incidence, Prediction and Outcome. Anaesthesia 1983; 38: 628 – 634

Naicker S, Aboud O and Gharbi MB: Epidemiology of Acute Kidney Injury in Africa. Semin Nephrol. 2008 July; 28 (4): 348 – 353

Okunola O, Arogundade FA, Sanusi AA et al. Acute Renal Failure in the Intensive Care Unit; Aetiological Factors and Outcome. West Afr. J. Med 2009; 28(4):240-244

Adelekun TA, Ekwere TR and Akinsola A: The Pattern of Acute Toxic Nephropathy in Ile-Ife, Nigeria, West Afr. J. Med. 1999. Jan – Mar; 18 (1): 60 – 63

El Nahas AM and Bello AK: Chronic kidney disease: the global challenge. Lancet 2005; 365: 331 – 340.

National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: Am J Kidney Dis 2002; 39 (Suppl 1): S1 – S266.

Naicker S: End-stage renal disease in sub-Saharan and South Africa. Kidney Int 2003; 63 (Suppl 83); S119 – S 122.

Barsoum RS: End-stage renal disease in North Africa. Kidney Int 2003; 63 (Suppl 83): S111 – S114.

Barsoum RS: Chronic kidney disease in the developing world. N Engl J Med 2006; 354: 997 – 999.

Sumaili EK, Krzesinski JM, Zinga CV et al: Prevalence of chronic kidney disease in Kinshasa: results of a pilot study from the Democratic Republic of Congo. Nephrol Dial Transplant 2009; 24: 117 – 122.

Coresh J, Astor B, Greene T, Eknoyan G and Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1 – 12.

Zhang L, Zhang P, Wang F et al: Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis 2008; 51: 373 – 384.

Chadban SJ, Briganti EM, Kerr PG et al: Prevalence of kidney damage in Australian adults: the AusDiab Kidney Study. J Am Soc Nephrol 2003; 14: S131 – S138.

Oluyombo R: Pattern and prevalence of chronic kidney disease in Ilie Community, Osun State. A dissertation accepted by the Faculty of Internal Medicine, National Postgraduate Medical College of Nigeria for the award of Fellowship of the College (FMCP, Nephrology subspecialty). May 2010

Akinsola A, Sanusi AA, Adelekun TA and Arogundade FA. Magnitude of the problem of chronic renal failure in Nigerians. African Journal of Nephrology 2004; 8: 24 – 26.

Snow RW, Craig M, Deichmann U et al. Estimating mortality and disability due to malaria among non pregnant population. Bulletin of the World Health Organisation. 1999 ; 77 : 624-640

Kibukamusoke JW. The hazards of malarial nephropathy. Parasitol Today 1986. Apr ; 2(4) : 119-121

Barsoum RS. Malarial Acute Renal Failure. J. Am Soc. Nephrol 2000; 11 (11); 2147 – 2154

El Hadji FK, Diouf B, Niang A et al. Acute Renal Failure in Adults in Dakar. Saudi J. Kidney Dis Transpl. 1999.10; 513 – 514

Zewdu W. Acute Renal Failure in Addis Ababa, Ethiopia. A Prospective Study of 136 patients. Ethiop. Med. J. 1994; 32: 79 – 87

Olotu A, Lusingu J, Leach A et al . Efficacy of RTS,S/ ASO1E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomized controlled trial. The Lancet Infectious Diseases, 2011; 11(2): 102 - 109

Joint United Nations Programme on HIV/AIDS (UNAIDS) 2008. 2008 Report on the global AIDS epidemic. Available at http// www.unaids.org. Accessed on January 11, 2011.

Tenofovir Induced ARF in an HIV patient with normal renal function. Nephrol Dial Transpl. 2005: 20; 473 – 474

Coca et al. ARF associated with Am Tenofovir J. Med. Sci 2002; 324; 342 – 344

Brodie SB, Keller MJ, Ewenstein BM et al. Variation in incidence of indinavir – associated nephrolithiasis among HIV – positive patients. AIDS 1998; 12: 2433 – 2437

Szczech LA, Gupta SK, Habash R et al: The clinical epidemiology and course of the spectrum of renal diseases associated HIV infection. Kidney Int 2004; 66: 1145 – 1152.

Gerntholtz TE, Goetsch SJW and Katz I: HIV-related nephropathy: A South African perspective. Kidney Int 2006; 69: 1885 – 1991.

Seney FDJ, Burns DK and Silva FG. Acquired immunodeficiency syndrome and the kidney. Am J Kidney Dis 1990; 16: 1 – 13.

D’Agati V, Suh J, Carbone I et al: Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int 1989; 35: 1358 – 1370.

Han TM, Naicker S, Ramdal PK and Assounga AG: A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006; 69: 2243 – 2250.

Emem PC, Arogundade F, Sanusi A et al, Adelusola K, Wokoma F, Akinsola A: Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant 2008; 23: 741 – 746.

Wools-Kaloustian K, Gupta SK, Muloma E et al: Renal disease in an antiretroviral-naïve HIV – infected outpatient population in Kenya. Nephrol Dial Transplant 2007; 22: 2208 – 2212.

Wools-Kaloustian KK and Gupta SK. Will there be an epidemic of HIV-related chronic kidney disease in sub-Saharan Africa? Too soon to tell. Kidney Int 2008; 74: 845 – 847.

Peters PJ, Moore DM, Mermin J et al: Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int 2008; 74: 925 – 929.

UNAIDS fact sheet on HIV/AIDS prevention. UNAIDS report on the global AIDS epidemic 2010. Accessed 11/2/11. www.unaids.org

Steenkamp V and Steward MJ: Nephrotoxicity Associated with Exposure to Plant Toxins, with Particular reference to Africa. The Drug Monit. 2005. June 27 (3): 270 – 277

Kadiri S, Ogunlesi A, Osifade K et al. The causes and course of acute tubular necrosis in Nigerians. Afr. J. Med. Med Sc. 1992. Oct. (1) 91 – 96

Sulieman SM, Fadlalla M, Nasr MM et al. Poisoning with hair dye containing paraphenylene diamine. Ten years experience. Saudi J. Kidney Dis Transpl. 1995; 6(3) 286 – 289.

Luyckx VA, Ballantine R, Claeys M. et al. Herbal Remedy – Associated Acute Renal Failure Secondary to Cape aloes. Am. J. Kidney Dis. 2002; 39, 1 – 3

Luyckx VA and Naicker S. Acute Kidney Injury Associated with the Use of Traditional Medicines. Nature Clinical Practice Nephrology, 2008, Vol. 4. Nos 12, 664 – 671

Sontz E and Schwieger J. The “Green Water” syndrome: Copper-induced hemolysis and subsequent acute renal failure as a consequence of a religious ritual. Am J. Med. 1995; 98:311 – 315

Chugh KS. Snake bite induced acute renal failure in India. Kidney Int. 1989; 35: 891 – 907

Kibukamusoke JW, Davies DR and Hutt MS. Membranous Nephropathy due to skin lightening cream. BMJ 1974;2: 646 -647

Abiola-Keteyi EA, Akinsola A and Babatunde OA, Analgesic intake in a rural community in Osun State, Nigeria. Nigerian Journal of Health Sciences. 2003; 3(1), 23 - 26

Seedat YK, Naickers S and Rawat R. Racial differences in the causes of end stage renal failure in Nathal. S. Afr Med J. 1984. 65(24) 956-958

Ishola DA, Jr., Arogundate F. A., Sanusi AA and Akinsola A: Association of Hydrocarbon Exposure with Glomerulonephritis in Nigerians. A Case Control Study. Saudi Journal of Kidney Diseases and Transplant.2006; 17(1) 82-89

El mam M, Omran M, Nugud F. et al. Obstructive Uropathy in Sudanese Patients. Saudi J. Kidney Dis Transpl. 2006. Sept. 17 (3) 415 – 419

Olowu WA and Adelusola KA: Paediatric Acute Renal Failure in South Western Nigeria. Kidney Int. 2004; 66: 1541 – 1548

Zewdu W. Acute Renal Failure in Addis Ababa, Ethiopia; A prospective Study of 136 Patients. Ethiop Med. J. 1994 April; 32 (2): 79 – 87

Randeree IG, Czarnocki A, Modley J. et al. Acute renal failure in pregnancy in South Africa. Ren. Fail 1995; 17: 147 – 53

Mensah GA: Epidemiology of stroke and high blood pressure in Africa heart 2008; 94:697-705

Onwubere B and Kadiri S (eds) . Guidelines for the management of hypertension in Nigeria. A recommendation for healthcare providers prepared by the Nigerian Hypertension Society. Enugu. 1st Edition. Ezu books Limited . 2005.p.1-4

Lawes CMM, Hoom SV and Rodgers A, for the International Society of Hypertension: Global burden of blood pressure related disease, 2001. Lancet 2008; 371: 1513 – 1518.

Bidani AK and Griffin KA: Pathophysiology of hypertensive renal damage: implications for therapy. Hypertension 2004; 44: 595 – 601.

Fogo AB and Marcantoni C: A perspective on arterionephrosclerosis: from pathology to potential pathogenesis. J Nephrol 2007; 20: 518 – 524.

Zandi-Nejad K, Luyckx VA andBrenner BM. Adult hypertension and kidney disease: the role of fetal programming. Hypertension 2006 Mar ; 47 (3): 502 -508.

Luyckx VA and Brenner BM. Low birth weight , nephron number, and kidney disease. Kidney Int suppl. 2005 Aug : (97): S68-77

Kao WH, Klag MJ, Meoni LA et al. Family Investigation of Nephropathy and Diabetes Research Group : MYH9 is associated with non diabetic end-stage renal disease in African Americans. Nat Genet 2008; 40 : 1185-1192

Naicker S: Challenges for Nephrology Practice in Sub-Saharan Africa. Nephrol Dial Transplant 2010; 25: 649 - 650

Akinsola W, Odesanmi WO, Ogunniyi JO and Ladipo GOA: Diseases causing chronic renal failure in Nigerians – A prospective study of 100 cases. Afr J Med med Sci 1989; 18: 131 – 135.

Matekole M, Affram K, Lee SJ et al, Howie AJ, Michael J, Adu D. Hypertension and end-stage renal failure in tropical Africa. J Human Hypertens 1993; 7: 443 – 446.

Buargub MA: 5 year mortality in haemodialysis patients: a single centre study in Tripoli. Saudi J Kidney Dis Transpl 2008; 19: 268 – 273.

Adelekun TA and Akinsola A. Hypertension induced Chronic renal failure, clinical features, management and prognosis. West Afr J Med. 1998; 17(2) : 104-108.

Bhimma R and Coovadia HM. Hepatitis B Virus associated Nephropathy. Am J Nephrol 2004; 24:198-211

Ayodele OE, Salako BL, Kadiri S. et al. Hepatitis B virus infection; implications in chronic kidney disease, dialysis and transplantation. Afr J Med. Med Sci 2006;35(2):111-119

Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996; 33(suppl 2):31-36

Madhava V, Burgess C and Drucker E. Epidemiology of Chronic hepatitis C virus infection in sub Saharan Africa. Pediatr nephrol 1998 Aug; 12(6):479-484

Van Buvien AJ, Bates WD and Muller N. Nephrotic syndrome in Namibian children. Afr. J. Med. Med . Sci 2006; 35(2):111-119

Akinsola A, Olusanya O and Iyun AO: Role of hepatitis Bs antigen in chronic glomerulonephrities in Nigerians. Afr J. Med. Med Sci 1984; 13(1-2)33-39

Lai M, Lai K N ,Chan KW et al. Pattern of glomerulonephritis in Hong Kong.Pathology 1987;19:247-252

Venkataseshan VS, Lieberman K, Kim Du et al: Hepatitis B associated glomerulonephritis; pathology pathogenesis and clinical course. Medicine (Baltimore). 1990:69(4):708-716

Diabetes cases in Africa to double in next 25 years. Bull World Health Organisation, ISSN 0042-9686, May 2004, 82(5): 397-398

Wild S, Roglic G, Green A, Sicree R and King K: Global prevalence of diabetes. Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047 – 1053.

Levitt NS: Diabetes in Africa: epidemiology, management and health care challenges. Heart 2008; 94: 1376 – 1382.

Kengne AP, Amoah AGB and Mbanya JC: Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation 2005; 112: 3592 – 3601.

Sobngwi E, Mauvais-Jarvis F, Vexian P, Mbanya JC and Gautier JF. Diabetes in Africans 1: epidemiology and clinical specificities. Diabetes Metab 2001; 27: 628 – 634.

Alebiosu CO. Clinical diabetic nephropathy in a tropical African population. West Afr. J. Med 2003 June; 22(2):152-155

Arogundade FA, Sanusi AA, Hassan MO et al: An appraisal of kidney dysfunction and its risk factors in patients with sickle cell disease. Nephron Clin Pract. 2011; 118; 225-231

Agaba EI , Duguru M, Agaba PA. Serum lipid profile of Nigerian diabetics with End stage renal disease. West afr J Med 2005 24(4); 305- 308

Afifi A and M. A. Karim. Renal Replacement therapy in Egypt. First Annual Report of the Egyptian Society of Nephrology, 1996 Eastern Mediterranean Health Journal. 1999; 5(5): 1023 – 1029

Mate-Kole MO, Yeboah ED, Affram RK et al. Haemodialysis in the treatment of acute renal failure in tropical Africa. A 20 year review at the Korle BU Teaching Hospital, Accra. Ren. Fail. 1996 May; 18 (3): 517 – 524

Elhassan AM, Kaballo B, Fedail H. et al. Peritoneal dialysis in the Sudan. Perit Dial Int; 2007; 27 (5): 503 – 510

Philip kam-tao Li and Cheuk-chunn Szeto. Success of the peritoneal dialysis programme in Hong-kong. Nephol. Dial Transpl 2008 23(5);1475-1478.

Alfonso M cueto-Manzano. Peritoneal dialysis in Mexico. Kidney Int( 2003) 63,S90-S72.

Abu-Aisha H and Elamin S. Peritoneal Dialysis in Africa. Perit Dial Int. 2010: 30(1):23-28

Naicker S. End Stage Renal Disease in Sub Saharan Africa. Ethn and Disease. 2009; 19: S1 – S13

Moosa MR and Kidd M: The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006; 70: 1107 – 1114.

Chugh KS and Jha V. Differences in the care of ESRD patients worldwide: required resources and future outlook. Kidney Int 1995; 48 (Suppl 50): S7 –S13.

Kher V. End stage renal disease in developing countries. Nephrology Forum. Kidney Int. 2002; 62: 350 – 362.

Arije A, Kadiri S and Akinkugbe OO. The viability of haemodialysis as a treatment option for renal failure in a developing economy. Afr J Med med Sci 2000; 29: 311 – 314.

Katz IJ, Sofianou L and Hopley M: An African community-based chronic ambulatory peritoneal dialysis programme. Nephrol Dial Transplant 2001; 16: 2395 – 2400

White SL, Chadban SJ, Jan S and Chapman JR, Cass A: How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organization 2008; 86: 229 – 237.